uk 68798 has been researched along with Atrial Flutter in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (30.56) | 18.2507 |
| 2000's | 23 (63.89) | 29.6817 |
| 2010's | 2 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussain, S; Maraj, I; Naccarelli, GV; Wolbrette, DL | 1 |
| Abraham, JM; Bassiouny, M; Bhargava, M; Janiszewski, D; Lawrence, D; Lindsay, B; Militello, M; Nissen, SE; Poe, S; Saliba, WI; Tanaka-Esposito, C; Vekstein, C; Wilkoff, BL; Wolski, K | 1 |
| Banchs, JE; Gonzalez, MD; Naccarelli, GV; Patel, PP; Penny-Peterson, ED; Samii, SM; Wolbrette, DL; Young, SK | 1 |
| Chawla, D; Coleman, CI; Ghatak, A; Kluger, J; Sood, N; Talati, R | 1 |
| Cleland, JG; Deedwania, PC; Khand, AU | 1 |
| Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Torp-Petersen, C | 1 |
| Kramer, JM; LaPointe, NM; Pamer, CA | 1 |
| Khan, IA | 2 |
| Roukoz, H; Saliba, W | 1 |
| Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T | 1 |
| Burke, P; Khawaja, O; Machado, C; Sekulic, M; Serafimovski, N | 1 |
| Crijns, HJ; Dunselman, PH; Gosselink, AT; Kingma, JH; Lie, KI; Van Gelder, IC | 1 |
| Atarashi, H; Hayakawa, H; Ino, T; Kuruma, A; Nomura, A; Yashima, M | 1 |
| Cha, Y; Feld, GK; Sawhney, N; Shahrokni, S; Wales, A; Wolf, P | 1 |
| Olshansky, B | 1 |
| Falk, RH; Friedrich, T; Pollak, A; Singh, SN | 1 |
| Singh, BN | 1 |
| Christiansen, EH; Christiansen, N; Frost, L; Mortensen, PE; Platou, ES; Tingleff, J | 1 |
| Christensen, PD; Christiansen, EH; Graff, O; Johansen, JB; Madsen, B; Nørgaard, BL; Simonsen, EH; Wachtell, K | 1 |
| Choy, AM; Darbar, D; Dell'Orto, S; Roden, DM | 1 |
| Markham, A; McClellan, KJ | 1 |
| Crijns, HJ; Dunselman, PH; Kingma, JH; Lindeboom, JE | 1 |
| Alboni, P; Bianconi, L; Castro, A; Dinelli, M; Pappalardo, A; Richiardi, E; Santini, M | 1 |
| DeCara, JM; Dubrey, S; Falk, RH; Pollak, A | 1 |
| Decara, JM; Falk, RH | 1 |
| Berk, M; Billing, CB; Brodsky, MA; Feld, GK; Singh, S; Yellen, L; Zoble, RG | 1 |
| DiMarco, JP; Mounsey, JP | 1 |
| Agner, E; Bloch Thomsen, PE; Camm, AJ; Carlsen, J; Egstrup, K; Køber, L; Marchant, B; Møller, M; Sandøe, E; Torp-Pedersen, C; Videbaek, J | 1 |
| Knobloch, K; Wirth, KJ | 1 |
| Lauer, MR | 1 |
| Vergara, G | 1 |
| Bagger, H; Keller, N; Køber, L; Marchant, B; Pedersen, OD; Torp-Pedersen, C | 1 |
| Assadi, MA; Brooks, RR; Caref, EB; El-Hamami, M; El-Sherif, N; Hegazy, M; Restivo, M; Yin, H | 1 |
| Milad, A; Racine, E; Tran, A; Vichiendilokkul, A | 1 |
| Dunselman, PH; Kingma, JH; Polak, PE; Rasmussen, HS; Suttorp, MJ; van 't Hof, A | 1 |
10 review(s) available for uk 68798 and Atrial Flutter
| Article | Year |
|---|---|
A Quarter of a Century Later: What is Dofetilide's Clinical Role Today?
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Decision-Making; Heart Conduction System; Heart Rate; Humans; Patient Selection; Phenethylamines; Potassium Channel Blockers; Risk Factors; Sulfonamides; Treatment Outcome | 2019 |
Prevention of and medical therapy for atrial arrhythmias in heart failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Carbazoles; Carvedilol; Drug Therapy, Combination; Electric Countershock; Heart Failure; Humans; Pacemaker, Artificial; Phenethylamines; Propanolamines; Software Design; Sulfonamides | 2002 |
Dofetilide: a new drug to control cardiac arrhythmia.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Phenethylamines; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Sulfonamides; Tachycardia, Supraventricular | 2003 |
Atrial stunning: basics and clinical considerations.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function; Atrial Function, Left; Atrial Function, Right; Catheter Ablation; Electric Countershock; Humans; Isoproterenol; Myocardial Stunning; Phenethylamines; Sotalol; Sulfonamides; Thromboembolism; Time Factors; Verapamil | 2003 |
Dofetilide: a new class III antiarrhythmic agent.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiologic Techniques, Cardiac; Heart Failure; Humans; Phenethylamines; Randomized Controlled Trials as Topic; Sulfonamides; Tachycardia, Supraventricular; Torsades de Pointes; Ventricular Function, Left | 2007 |
Dofetilide versus quinidine for atrial flutter: viva la difference!?
Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Phenethylamines; Quinidine; Sulfonamides | 1996 |
Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Phenethylamines; Sulfonamides | 1999 |
Dofetilide: a new pure class III antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Drug Administration Schedule; Electrophysiology; Food-Drug Interactions; Heart Conduction System; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Tachycardia; Ventricular Dysfunction | 2000 |
Cardiovascular drugs. Dofetilide.
Topics: Action Potentials; Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels; Reaction Time; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 2000 |
Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Appendage; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Dogs; Electric Countershock; Heart Atria; Humans; Myocardial Contraction; Myocardial Stunning; Phenethylamines; Regional Blood Flow; Sotalol; Sulfonamides; Ultrasonography; Verapamil | 2002 |
12 trial(s) available for uk 68798 and Atrial Flutter
| Article | Year |
|---|---|
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment | 2007 |
Usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Length of Stay; Male; Michigan; Phenethylamines; Postoperative Complications; Potassium Channel Blockers; Potassium Channels; Retrospective Studies; Sulfonamides; Survival Rate; Treatment Outcome | 2008 |
Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.
Topics: Anti-Arrhythmia Agents; Atrial Flutter; Double-Blind Method; Echocardiography; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Sulfonamides | 1994 |
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Hemodynamics; Humans; Phenethylamines; Sulfonamides; Treatment Outcome | 1997 |
Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Confidence Intervals; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenethylamines; Placebo Effect; Postoperative Complications; Sample Size; Sulfonamides; Treatment Outcome | 1997 |
Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Denmark; Double-Blind Method; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Placebos; Potassium Channel Blockers; Prospective Studies; Safety; Sulfonamides; Time Factors | 1999 |
Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Safety; Sulfonamides; Time Factors | 2000 |
Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Prognosis; Sulfonamides; Vasodilator Agents | 2000 |
Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Flow Velocity; Double-Blind Method; Echocardiography, Doppler, Color; Electric Countershock; Heart Rate; Humans; Myocardial Contraction; Phenethylamines; Potassium Channel Blockers; Recurrence; Stroke Volume; Sulfonamides | 2000 |
Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Placebos; Sulfonamides; Treatment Outcome | 2000 |
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Sulfonamides; Ventricular Dysfunction, Left | 2000 |
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Denmark; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Phenethylamines; Sulfonamides; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
14 other study(ies) available for uk 68798 and Atrial Flutter
| Article | Year |
|---|---|
Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cause of Death; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Ohio; Phenethylamines; Retrospective Studies; Sulfonamides; Treatment Outcome | 2015 |
Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Electrocardiography; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Treatment Outcome | 2008 |
Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Cohort Studies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides; Treatment Outcome | 2009 |
New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Databases, Factual; Drug Prescriptions; Drug Utilization; Humans; Phenethylamines; Sotalol; Sulfonamides; United States | 2003 |
Use of intravenous dofetilide in atrial flutter with hemodynamic instability.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Flutter; Blood Pressure; Female; Heart Rate; Humans; Injections, Intravenous; Phenethylamines; Sulfonamides | 1996 |
Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Flutter; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction System; Phenethylamines; Quinidine; Sulfonamides; Treatment Outcome | 1996 |
Acute conversion of atrial fibrillation and flutter: direct current cardioversion versus intravenously administered pure class III agents.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Humans; Phenethylamines; Sulfonamides; Treatment Outcome | 1997 |
Exaggerated QT prolongation after cardioversion of atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Male; Phenethylamines; Sulfonamides | 1999 |
Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Atrial Function, Right; Flecainide; Male; Phenethylamines; Propafenone; Sulfonamides; Swine | 2001 |
Dofetilide: is the treatment worse than the disease?
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular | 2001 |
[Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Clinical Trials as Topic; Humans; Phenethylamines; Sulfonamides | 2001 |
Efficacy of azimilide and dofetilide in the dog right atrial enlargement model of atrial flutter.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Cardiomegaly; Dogs; Drug Evaluation, Preclinical; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Sulfonamides | 2001 |
Practical approach to the use and monitoring of dofetilide therapy.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Monitoring; Humans; Phenethylamines; Sulfonamides | 2001 |
Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Paroxysmal | 1992 |